The article focuses on an alternative approach to treating chronic insomnia using dual orexin receptor antagonists (DORAs) such as daridorexant, lemborexant, and suvorexant, which directly address hyperarousal without the issues of tolerance or withdrawal associated with traditional hypnotics. Topics include the unnecessary use of an alternating medication strategy, the efficacy and safety profile of DORAs.